Medically reviewed by Dr Bhavin Garara, GMC 7155707 · Last reviewed: 4 May 2026
Rosacea is a recognised medical condition. This page is general information, not a diagnosis. More than one condition can produce facial redness (including lupus and seborrhoeic dermatitis, among others). Dr Garara will assess your skin and history in person, confirm what is actually going on, and only then discuss whether aesthetic treatment is appropriate for you. Severe or rapidly worsening rosacea benefits from GP or dermatology assessment for medical management.
Rosacea involves chronic inflammation of the facial skin and small blood vessels, producing visible redness and a tendency to flush. The condition is variable — some patients have constant redness, others mainly flushing episodes, and others a combination with small bumps. The mechanisms involved include vascular hyper-reactivity, an over-active innate immune response, an imbalance of skin micro-organisms (including Demodex mite involvement in some patients), and a compromised skin barrier.
Dr Bhavin Garara’s approach is structured around understanding which features dominate for the individual patient — vascular, inflammatory, or barrier — and tailoring treatment accordingly.
Different clinical subtypes call for different priorities.
Persistent central facial redness with visible broken capillaries. Most responsive to vascular laser.
Redness with small red bumps and pustules. Often benefits from medical management alongside vascular laser.
Thickening of skin, particularly on the nose (rhinophyma). Usually warrants dermatological / surgical assessment.
Eye involvement (grittiness, redness, dryness). The right pathway is ophthalmology assessment.
Most patients have a mixed pattern combining elements of the above.
Family history is a strong risk factor. Rosacea is more common in patients of Northern European descent.
The small blood vessels of the central face are more reactive to triggers than in unaffected skin.
Sun exposure, heat (saunas, hot drinks), spicy food, alcohol, stress, and certain skincare products commonly trigger flushing.
Rosacea-affected skin often has a compromised barrier, allowing irritants to provoke inflammation more easily.
In some patients an over-representation of Demodex folliculorum contributes to the inflammatory component.
Perimenopausal and menopausal flushing can overlap with or aggravate rosacea.
At the clinics in London, Dr Garara assesses subtype, severity, dominant features, trigger pattern, current skincare routine, and any indication for medical management. The plan usually combines vascular laser for the visible vessels and chronic redness, regenerative skin treatments for barrier repair, careful trigger management, and GP / dermatology referral where prescription medical treatment is indicated.
Prevention
Consistent trigger management and gentle daily care are central to controlling rosacea.
Prevention
Consistent trigger management and gentle daily care are central to controlling rosacea.
Features
Vascular laser, radiofrequency microneedling, regenerative skin treatments, and prescription medical management.
Treatment is layered — vascular laser for visible vessels and chronic redness, radiofrequency microneedling for reactive skin, regenerative support for barrier repair, and prescription medical management where indicated.
For the most visible features of rosacea — persistent redness and broken capillaries — Derma V delivers specific wavelengths absorbed by haemoglobin in dilated vessels, designed to collapse the visible vessels and reduce overall background redness. Multiple sessions are usually needed.
Sylfirm X delivers radiofrequency through fine needles into the dermis and is used in this concern to support tissue and reduce micro-vessel density over a course. Treatment for higher Fitzpatrick skin types (IV–VI) requires careful device selection and conservative settings; Dr Garara has particular experience in aesthetic medicine for skin of colour.
For barrier repair and calming, polynucleotides (Rejuran®), PDRN, multi-ingredient skinboosters (Profhilo, klardie, NCTF), and autologous PRP / platelet-derived exosomes support skin quality and resilience. A short course is typical.
Many rosacea patients benefit from prescription medical care alongside aesthetic treatment — topical metronidazole, ivermectin, azelaic acid; oral antibiotics in some cases; brimonidine for short-term redness control; isotretinoin in selected severe presentations. Dr Garara will route to GP / dermatology where medical management is indicated.
For the most visible features of rosacea — persistent redness and broken capillaries — Derma V delivers specific wavelengths absorbed by haemoglobin in dilated vessels, designed to collapse the visible vessels and reduce overall background redness. Multiple sessions are usually needed.
Book a consultation with Dr Bhavin Garara.
Book a Consultation| Treatment | Best suited for | Typical downtime | How long results last | What it does |
|---|---|---|---|---|
| Vascular laser | Persistent redness and broken capillaries | 1–3 days of mild swelling or redness | Long-lasting; some maintenance usually needed | Targets visible blood vessels |
| Radiofrequency microneedling | Reactive skin with micro-vessel involvement | 2–4 days of mild redness | Long-lasting; benefits build over months | Supports tissue and reduces micro-vessel density |
| Skinboosters / polynucleotides / PRP / exosomes | Barrier repair and calming | 1–2 days of mild bumps | Around 6–12 months with a course | Supports skin quality and resilience |
| Medical management (GP / dermatology) | Papulopustular rosacea, severe or treatment-resistant | N/A | Long-term medical care | Prescription topical / oral treatment |
| Trigger management and home care | Daily foundation for all rosacea management | None | Ongoing | Reduces flare frequency |
Downtime and duration figures are typical averages only. Individual results vary considerably. Dr Garara will give you a more personalised picture at consultation.
Vascular laser and radiofrequency microneedling are widely performed on rosacea-affected skin and generally well tolerated. Common short-term effects are transient redness, mild swelling, and bruising of treated vessels. As with any energy-based treatment, technique matters — settings are tailored to skin type and rosacea subtype to reduce the risk of post-inflammatory pigment change.
We share this not to alarm you but because patients deserve full information. Dr Garara is happy to discuss specific risks at consultation. Severe or treatment-resistant rosacea benefits from medical management; we will recommend GP / dermatology referral where that is the right answer.
Common questions about treating rosacea.
Rosacea connects to other skin concerns. You may also want to read about:
For an overview of all the facial concerns we treat, visit our Skin treatments hub.
Tell us a little about what you're looking for and we'll match you with the right consultation — at the clinic or virtually.
This page is for general information and does not constitute medical advice. All treatments require a personal consultation. Suitability, risks, and expected outcomes will be discussed with you in detail before any treatment is carried out.
